Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Stampacchia Otello
Relationship:   Director
City:   George Town, Grand Cayman
State:   E9
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   17,297,599    

Indirect Shares

  21,254,784      
Direct Value   $106,045,692    

Indirect Value

  $133,311,703      
Total Shares   38,552,383      
Total Value   $239,357,395      


Gossamer Bio Inc
 $3,469,567 Morphic Holding, Inc.
 $60,515,705 Replimune Group Inc
 $42,060,420 Kronos Bio, Inc.
 $0 Gossamer Bio Inc
 $3,469,567 Morphic Holding, Inc.
 $60,515,705 Replimune Group Inc
 $42,060,420 Kronos Bio, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 78.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Gossamer Bio Inc GOSS Former director., 10% ... 2019-09-18 6,737,023 2019-02-12 6,953,416    Premium*  
            Morphic Holding, Inc. MORF Director 2021-04-30 2,068,913 2019-07-01 2,969,582    Premium*  
            Replimune Group Inc REPL 10% Owner 2022-03-16 4,673,380 2022-03-14 4,763,380    Premium*  
            Kronos Bio, Inc. KRON Director 2020-10-14 3,818,283 2020-10-14 3,818,283    Premium*  
            Omega Alpha Spac OMEG Chief Executive Office... 0 2021-01-11 501,000    Premium*  
            Ikena Oncology, Inc. IKNA Director 2021-03-30 0 2021-03-30 2,249,123    Premium*  
* Premium Members only  

Records found :    119         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GOSS Gossamer Bio Inc Director   –       •       •   2019-02-12 4 A $0.00 $0 I/I 6,953,416 6,953,416 0 -
MORF Morphic Holding, Inc. Director   –       •       •   2019-07-01 4 A $0.00 $0 D/D 2,836,249 2,836,249 0 -
MORF Morphic Holding, Inc. Director   –       •       •   2019-07-01 4 A $0.00 $0 I/I 2,836,249 2,836,249 0 -
KRON Kronos Bio, Inc. Director   –       •       •   2020-10-14 4 A $0.00 $5,915,729 I/I 3,348,832 3,368,283 0 -
KRON Kronos Bio, Inc. Director   –       •      –    2020-10-14 4 A $0.00 $5,915,729 D/D 3,348,832 3,368,283 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2021-03-30 4 A $16.00 $7,200,000 I/I 450,000 2,249,123 0 -
IKNA Ikena Oncology, Inc. Director   –       •      –    2021-03-30 4 A $0.00 $0 I/I 1,799,123 1,799,123 0 -
MORF Morphic Holding, Inc. Director   –       •      –    2020-12-23 4 AS $33.34 $305,162 D/D (9,142) 2,968,690 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2020-12-24 4 AS $32.48 $94,220 D/D (2,883) 2,965,807 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2020-12-28 4 AS $32.34 $306,266 D/D (9,466) 2,956,341 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2020-12-29 4 AS $31.75 $331,149 D/D (10,428) 2,945,913 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-04 4 AS $32.57 $396,305 D/D (12,118) 2,917,903 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-05 4 AS $30.89 $414,088 D/D (13,324) 2,904,579 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-06 4 AS $30.09 $361,923 D/D (12,024) 2,892,555 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-07 4 AS $29.98 $483,907 D/D (16,141) 2,876,414 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-08 4 AS $30.13 $271,984 D/D (9,027) 2,867,387 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-11 4 AS $30.15 $101,967 D/D (3,382) 2,864,005 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-12 4 AS $30.10 $173,316 D/D (5,758) 2,858,247 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-13 4 AS $30.11 $202,941 D/D (6,740) 2,851,507 0 %
REPL Replimune Group Inc Director   –       •      –    2021-01-14 4 AS $45.09 $796,470 D/D (17,664) 5,327,307 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-14 4 AS $30.27 $282,809 D/D (9,241) 2,842,266 0 %
REPL Replimune Group Inc Director   –       •      –    2021-01-15 4 AS $45.19 $86,584 D/D (1,916) 5,325,391 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-15 4 AS $30.49 $435,672 D/D (14,289) 2,827,977 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-19 4 AS $29.95 $517,888 D/D (17,238) 2,810,739 0 %
MORF Morphic Holding, Inc. Director   –       •      –    2021-01-21 4 AS $29.98 $7,915 D/D (264) 2,810,475 0 %

  119  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed